It should be noted that ROCK2 is the dominant isoform in brain, heart, and smooth muscle cells [21], and, thus, inhibitors that specifically target ROCK2 are desirable in the context of neurodegenerative diseases. The gene discussed is ROCK2; the disease is neurodegenerative disease.